受强制性开放获取政策约束的文章 - Praveen Ramakrishnan Geethakumari了解详情
无法在其他位置公开访问的文章：2 篇
PARP inhibitors in prostate cancer
P Ramakrishnan Geethakumari, MJ Schiewer, KE Knudsen, WK Kelly
Current treatment options in oncology 18, 1-16, 2017
强制性开放获取政策： US National Institutes of Health
Final Result of DIAL (NCI10089), Randomized Phase 2 trial of Varlilumab combined with Nivolumab in patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma.
CY Soekojo, J Yin, J Kline, A Lazaryan, N Bartlett, PR Geethakumari, ...
Hematological Oncology 41, 2023
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Lymphoma …
可在其他位置公开访问的文章：26 篇
Cytotoxic responses to 405 nm light exposure in mammalian and bacterial cells: Involvement of reactive oxygen species
P Ramakrishnan, M Maclean, SJ MacGregor, JG Anderson, MH Grant
Toxicology in vitro 33, 54-62, 2016
强制性开放获取政策： UK Engineering and Physical Sciences Research Council
The effects of 405 nm light on bacterial membrane integrity determined by salt and bile tolerance assays, leakage of UV-absorbing material and SYTOX green labelling
K McKenzie, M Maclean, MH Grant, P Ramakrishnan, SJ MacGregor, ...
Microbiology 162 (9), 1680-1688, 2016
强制性开放获取政策： UK Engineering and Physical Sciences Research Council
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
SM Smith, J Godfrey, KW Ahn, A DiGilio, S Ahmed, V Agrawal, ...
Cancer 124 (12), 2541-2551, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Increasing colon cancer screening in primary care among African Americans
RE Myers, R Sifri, C Daskalakis, M DiCarlo, PR Geethakumari, J Cocroft, ...
Journal of the National Cancer Institute 106 (12), dju344, 2014
强制性开放获取政策： US National Institutes of Health
Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant
M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ...
JAMA oncology 7 (7), 993-1003, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Association of reduced-intensity conditioning regimens with overall survival among patients with non-Hodgkin lymphoma undergoing allogeneic transplant
N Ghosh, S Ahmed, KW Ahn, M Khanal, C Litovich, M Aljurf, VU Bacher, ...
JAMA oncology 6 (7), 1011-1018, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Patient-Centered …
Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challenge
PR Geethakumari, MS Hoffmann, N Pemmaraju, S Hu, JL Jorgensen, ...
Clinical Lymphoma Myeloma and Leukemia 14 (4), e115-e118, 2014
强制性开放获取政策： US National Institutes of Health
Differential sensitivity of osteoblasts and bacterial pathogens to 405-nm light highlighting potential for decontamination applications in orthopedic surgery
P Ramakrishnan, M Maclean, SJ MacGregor, JG Anderson, MH Grant
Journal of biomedical optics 19 (10), 105001-105001, 2014
强制性开放获取政策： UK Engineering and Physical Sciences Research Council
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma …
N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ...
Journal of Hematology & Oncology 12, 1-11, 2019
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation
D Jagadeesh, NS Majhail, Y He, KW Ahn, C Litovich, S Ahmed, M Aljurf, ...
Cancer 126 (10), 2279-2287, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Patient-Centered …
The association between EGFR and cMET expression and phosphorylation and its prognostic implication in patients with breast cancer
YK Chae, DM Gagliato, SG Pai, B Carneiro, N Mohindra, FJ Giles, ...
PLoS One 11 (4), e0152585, 2016
强制性开放获取政策： US National Institutes of Health
Targeting the inducible T-cell costimulator (ICOS) in patients with relapsed/refractory T-follicular helper phenotype peripheral T-cell and angioimmunoblastic T-cell lymphoma
JC Chavez, FM Foss, BM William, JE Brammer, SM Smith, A Prica, ...
Clinical Cancer Research 29 (10), 1869-1878, 2023
强制性开放获取政策： US National Institutes of Health
Cardiovascular disease and chimeric antigen receptor cellular therapy
A Rao, A Stewart, M Eljalby, P Ramakrishnan, LD Anderson Jr, FT Awan, ...
Frontiers in Cardiovascular Medicine 9, 932347, 2022
强制性开放获取政策： Cancer Prevention Research Institute of Texas, USA
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: a US multisite study
N Epperla, RL Welkie, P Torka, G Shouse, R Karmali, L Shea, ...
Journal of Hematology & Oncology 16 (1), 49, 2023
强制性开放获取政策： US National Institutes of Health
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
N Epperla, Q Zhao, R Karmali, P Torka, L Shea, TS Oh, ...
Blood Advances 7 (17), 5038-5046, 2023
强制性开放获取政策： US National Institutes of Health
Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy
A Mulgaonkar, D Udayakumar, Y Yang, S Harris, OK Öz, ...
Frontiers in Medicine 10, 1199146, 2023
强制性开放获取政策： US Department of Defense, Cancer Prevention Research Institute of Texas, USA
Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting
AM Patel, O Ali, R Kainthla, SM Rizvi, FT Awan, T Patel, E Pan, E Maher, ...
Neuro-Oncology Practice 9 (3), 183-192, 2022
强制性开放获取政策： Swedish Research Council
Phase 1 and Dose Expansion Study of APR-246 in Combination with Ibrutinib or Venetoclax-based therapy in Subjects with TP53-Mutant Relapsed and/or Refractory Non-Hodgkin …
et al. Thompson MC, Attar EA, Ramakrishnan Geethakumari P, Mato A
Blood 136 (Supplement 1), 15-16, 2020
强制性开放获取政策： Ford Foundation
出版信息和资助信息由计算机程序自动确定